Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AtriCure, Inc. - Common Stock (NQ:ATRC)

37.12 +0.01 (+0.03%)
Streaming Delayed Price Updated: 3:00 PM EST, Feb 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AtriCure, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
AtriCure: Q2 Earnings Insights ↗
AtriCure (NASDAQ:ATRC) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings AtriCure missed estimated earnings by... 
Via Benzinga
News headline image
AtriCure Reports Second Quarter 2022 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate at Upcoming Investor Conferences
From AtriCure, Inc.
Via Business Wire
News headline image
5 Analysts Have This to Say About AtriCure ↗
Over the past 3 months, 5 analysts have published their opinion on AtriCure (NASDAQ:ATRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
AtriCure to Announce Second Quarter 2022 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
Analyst Ratings for AtriCure ↗
Over the past 3 months, 4 analysts have published their opinion on AtriCure (NASDAQ:ATRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
AtriCure Announces the First Patient Treated in the HEAL-IST Clinical Trial
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Announces the Appointment of Deborah Yount as Chief Human Resources Officer
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure's Q1 EPS Miss Estimates, Needham Lowers Price Target ↗
Needham lowered AtriCure Inc's (NASDAQ: ATRC) price target to $67 from $79 due to peer multiple compression, with the Buy rating unchanged. 
Via Benzinga
News headline image
4 Analysts Have This to Say About AtriCure ↗
Over the past 3 months, 4 analysts have published their opinion on AtriCure (NASDAQ:ATRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
AtriCure: Q1 Earnings Insights ↗
AtriCure (NASDAQ:ATRC) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings AtriCure missed estimated earnings by... 
Via Benzinga
News headline image
AtriCure Reports First Quarter 2022 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Launches EnCompass® Clamp, a part of Isolator Synergy™ Ablation System
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Announce First Quarter 2022 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Reports Deeper Losses In Q4 Despite 27% Jump In Sales, Issues FY22 Guidance ↗
AtriCure Inc (NASDAQ: ATRC) reported Q4 
Via Benzinga
News headline image
Recap: AtriCure Q4 Earnings ↗
AtriCure (NASDAQ:ATRC) reported its Q4 earnings results on Tuesday, February 15, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings AtriCure missed estimated earnings... 
Via Benzinga
News headline image
AtriCure Reports Fourth Quarter 2021 and Full Year 2021 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus ImmunityBio Says Cancer Combo Therapy Produces Positive Results In Late-Stage... 
Via Benzinga
News headline image
Earnings Scheduled For February 15, 2022 ↗
Companies Reporting Before The Bell • FirstService (NASDAQ:FSV) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.07 billion. 
Via Benzinga
News headline image
A Preview Of AtriCure's Earnings ↗
AtriCure (NASDAQ:ATRC) is set to give its latest quarterly earnings report on Tuesday, 2022-02-15. Here's what investors need to know before the announcement. Analysts estimate that AtriCure will... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More ↗
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news... 
Via Benzinga
News headline image
AtriCure Publishes Inaugural ESG Report
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Announce Fourth Quarter and Full Year 2021 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2021, Provides Financial Outlook for 2022
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the 40th Annual J.P. Morgan Healthcare Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure, inc (ATRC) Q3 2021 Earnings Call Transcript ↗
ATRC earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
AtriCure Reports Third Quarter 2021 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics... 
Via Benzinga
Topics Retirement
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.